Vitamin B does not slow cognitive decline in Alzheimer's

October 15, 2008

A clinical trial led by Paul S. Aisen, M.D., professor of neurosciences at the University of California, San Diego School of Medicine, showed that high-dose vitamin B supplements did not slow the rate of cognitive decline in patients with mild to moderate Alzheimer disease. The study will be published in the October 15 issue of the Journal of the American Medical Association (JAMA).

Aisen is director of the Alzheimer's Disease Cooperative Study (ADCS), a multi-center network spanning the United States and Canada, which conducted the clinical trial to determine if reduction of an amino acid called homocysteine would reduce the risk of Alzheimer's disease or slow its progression. Homocysteine is known to be involved in neurological disease, including Alzheimer's, and its metabolism is affected by B vitamins. Therefore, it was thought that B vitamin supplements might offer a new therapeutic approach in treating Alzheimer' disease.

"Prior studies using B vitamin supplementation to reduce homocysteine levels in patients with Alzheimer's weren't large enough, or of long enough duration to effectively assess their impact on cognitive decline," said Aisen. "This study of several hundred individuals over the course of 18 months showed no impact on cognition, although it resulted in lower levels of homocysteine in these patients."

The study included supplementation with folic acid and vitamins B6 and B12 for 18 months in 409 individuals with mild to moderate Alzheimer's disease. Participants were randomly assigned to two groups of unequal size; to increase enrollment, 60 percent were treated with high-dose supplements and the remaining 40 percent treated with identical dosages of placebo. A total of 340 participants (202 in active treatment group and 138 in placebo group) completed the trial while taking study medication. Cognitive abilities were measured via testing with the Alzheimer Disease Assessment Scale (ADAS-cog).

The researchers found that the ADAS-cog score did not differ significantly between treatment groups, but that symptoms of depression were more common in the high-dose supplement group.

"Our study does not support the treatment of individuals with mild to moderate Alzheimer's disease and normal vitamin levels with B vitamin supplements," the authors conclude.

University of California - San Diego

---

---

	Insulin sensitizers cut cognitive decline in AD.(care and treatment)(clinical trials)(Alzheimer's disease): An article from: Clinical Psychiatry News by Robert Finn (Author) This digital document is an article from Clinical Psychiatry News, published by Thomson Gale on April 1, 2006. The length of the article is 683 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Insulin sensitizers cut cognitive decline in AD.(care and treatment)(clinical trials)(Alzheimer's disease) Author: Robert Finn Publication: Clinical Psychiatry News (Magazine/Journal) Date: April 1, 2006 Publisher: Thomson Gale Volume: 34 Issue: 4 Page: 42(1) Distributed by Thomson...
	Social and Motivational Compensatory Mechanisms for Age-Related Cognitive Decline (Special Issues of Aging Neurop) by Grzegorz Sedek (Editor), Paul Verhaeghen (Editor), Mike Martin (Editor) Although many aspects of fluid cognition decline with advancing age, simple observation in the wild suggests that older adults, generally speaking, do very well in their day-to-day life. The study of the orchestration of cognitive, social, and motivational compensatory mechanisms in the service of effective and healthy aging provides a meaningful challenge to traditional ways of examining developmental changes in cognitive performance. An additional impetus comes from recent discoveries in the neuroscience of aging, all demonstrating substantial amounts of functional modifiability, compensation, and plasticity of the human brain, even in very old age. Furthermore, the discovery of string relationships between engagement in mentally enriching and socially stimulating activities and...
	Diet And Cognitive Decline by Francesco Panza (Editor), Vincent Solfrizzi (Editor), Antonio Capurso (Editor) The progressive ageing of the general population and the consequent increase of the number of old people has made the typical medical problems of aged people more frequently observed, and particularly the problems related to the ageing brain. This new book is an updated overview of relevant aspects of cognitive decline associated with ageing. Within the wide landscape of brain ageing the authors reconsider the role of the main predisposing factors and risk factors on the development of various form of mental decline, from mild cognitive impairment to dementia. The strength of this book is the large, updated overview of the most recent data of scientific literature regarding the role of genetic, metabolic and environmental factors on the predisposition and onset of cognitive decline....
	Cognitive Psychology: Connecting Mind, Research and Everyday Experience with Coglab Manual by E. Bruce Goldstein (Author) Bruce Goldstein's COGNITIVE PSYCHOLOGY connects the study of cognition to your everyday life. This accessible book introduces you to landmark studies as well as the cutting-edge research that define this fascinating field. To help you further experiment with and understand the concepts in the text, you can use COGLAB 2.0: THE ONLINE COGNITIVE PSYCHOLOGY LABORATORY. Available at www.iChapters.com, COGLAB contains dozens of classic experiments designed to help you learn about cognitive concepts and how the mind works.
	Cognitive Rehabilitation: An Integrative Neuropsychological Approach by McKay Moore Sohlberg PhD CCC-SLP (Author), Catherine A. Mateer PhD (Author) Sohlberg and Mateer's landmark introductory text helped put cognitive rehabilitation on the map for a generation of clinicians, researchers, educators, and students. Now, more than a decade later, the discipline has come of age. This new volume provides a comprehensive overview of this fast-evolving field. More than a revised edition, the text reflects the dramatic impact of recent advances in neuroscience and computer technology, coupled with changes in service delivery models. The authors describe a broad range of clinical interventions for assisting persons with acquired cognitive impairments--including deficits in attention, memory, executive functions, and communication--and for managing associated emotional and behavioral issues. For each approach, theoretical underpinnings are...
	The Advanced Intelligence of Dolphin Man (The Emergence of Dophin Man and the Decline of Wise Man) by Authorhouse The Advanced Intelligence of Dolphin Man is a practical text to describe the affects to accumulate a new manner of sentience in reaction to prolonged persecution. The volume compares a Wise Man standard of a name and home. It is less a volume of the reflection and lop to a higher branch of a tree and more of a trait by trait withstanding of gun shots. The text focuses to spirit trait, memory expansion and calculation abilities of the creature of Dolphin Man. It is life magazine style and has numerous otherwise word defying series of photo.
	9 Ways to keep mental decline at bay.: An article from: Focus on Healthy Aging by Unavailable (Author)
	Neurofeedback--brain training for mental ills: biofeedback techniques show promise in treating such conditions as epilepsy, addiction, and cognitive decline.: An article from: Mind, Mood & Memory by Gale Reference Team (Author) This digital document is an article from Mind, Mood & Memory, published by Thomson Gale on December 1, 2006. The length of the article is 656 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Neurofeedback--brain training for mental ills: biofeedback techniques show promise in treating such conditions as epilepsy, addiction, and cognitive decline. Author: Gale Reference Team Publication: Mind, Mood & Memory (Magazine/Journal) Date: December 1, 2006 Publisher: Thomson Gale Volume: 2 Issue: 12 Page: 3(1) Distributed by Thomson...
	VASCULAR DEMENTIA: Stroke risk and sequelae define therapeutic approaches Although the mainstay of treatment remains control of risk factors for stroke, ... cognitive decline. (Postgraduate Medicine) by JTE Multimedia The symptoms of vascular dementia are often distinct from those of Alzheimer's disease. The memory deficits that define Alzheimer's disease are not always observed in the initial stages of vascular dementia, which is usually characterized by greater impairment of executive function. However, increasing evidence supports an involvement of the cholinergic system in vascular dementia similar to that seen in Alzheimer's disease. In this article, Dr Black reviews the pathogenesis and diagnosis of vascular dementia, risk factors for the disease, and current treatment approaches, including possible use of cholinesterase inhibitors. Original Publication Date: January 2005
	Cognitive decline linked to worsening depression.(Geriatrics): An article from: Internal Medicine News by Mitchel L. Zoler (Author) This digital document is an article from Internal Medicine News, published by International Medical News Group on January 1, 2005. The length of the article is 3552 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Cognitive decline linked to worsening depression.(Geriatrics) Author: Mitchel L. Zoler Publication: Internal Medicine News (Magazine/Journal) Date: January 1, 2005 Publisher: International Medical News Group Volume: 38 Issue: 1 Page: 32(1) Distributed by Thomson...